Volume 74, Issue 1, Pages (July 2018)

Slides:

Advertisements

Similar presentations

The Learning Curve in the Training of Percutaneous Nephrolithotomy

Advertisements

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 1, Pages (July 2010)

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Volume 70, Issue 1, Pages (July 2016)

Testosterone Therapy in Men With Prostate Cancer

Volume 63, Issue 5, Pages (May 2013)

Global Trends in Testicular Cancer Incidence and Mortality

Volume 53, Issue 4, Pages (April 2008)

Volume 61, Issue 5, Pages (May 2012)

Volume 64, Issue 4, Pages (October 2013)

Volume 50, Issue 5, Pages (November 2006)

Volume 53, Issue 5, Pages (May 2008)

Volume 66, Issue 6, Pages (December 2014)

Let the Games Begin (with EAU Approval)

Volume 71, Issue 5, Pages (May 2017)

Prostate Cancer Epidemic in Sight?

Volume 45, Issue 4, Pages (April 2004)

Bladder Cancer: A Major Public Health Issue

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 5, Pages (November 2015)

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 68, Issue 1, Pages (July 2015)

Volume 63, Issue 5, Pages (May 2013)

Obesity and Prostate Cancer: A Role for Adipokines

Volume 69, Issue 3, Pages (March 2016)

Volume 70, Issue 1, Pages (July 2016)

Volume 64, Issue 3, Pages (September 2013)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Volume 63, Issue 4, Pages (April 2013)

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Global Burden of Urologic Cancers, 1990–2013

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 4, Pages (April 2008)

Trends in Hypospadias Surgery: Results of a Worldwide Survey

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 52, Issue 1, Pages (July 2007)

The Economic Costs of Overactive Bladder in Germany

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

The Learning Curve in the Training of Percutaneous Nephrolithotomy

Volume 62, Issue 6, Pages (December 2012)

Volume 50, Issue 5, Pages (November 2006)

Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Testicular Cancer Variations in Time and Space in Europe

Volume 74, Issue 4, Pages (October 2018)

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Economic Burden of Bladder Cancer Across the European Union

Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 74, Issue 1, Pages 57-62 (July 2018) Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer Michal Sarfaty, Peter S. Hall, Kelvin K.W. Chan, Kiran Virik, Moshe Leshno, Noa Gordon, Assaf Moore, Victoria Neiman, Eli Rosenbaum, Daniel A. Goldstein European Urology Volume 74, Issue 1, Pages 57-62 (July 2018) DOI: 10.1016/j.eururo.2018.03.006 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Markov model. European Urology 2018 74, 57-62DOI: (10.1016/j.eururo.2018.03.006) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Cost-effectiveness acceptability curves in US dollars. QALY=quality-adjusted life-year. European Urology 2018 74, 57-62DOI: (10.1016/j.eururo.2018.03.006) Copyright © 2018 European Association of Urology Terms and Conditions